CSIRO, through its Division of Molecular and Health Technologies and Offspring Ventures, a subsidiary of QPSX Ltd, have entered into an arrangement to commercialize some of the Division’s ecdysone receptor technology.
06/12/2005 - 21:00
QPSX Ltd30-Nov-05
06/12/2005 - 21:00
